{"entity":{"type":"insider","cik":"0001379349","url":"/insider/0001379349","json_url":"/insider/0001379349.json","name":"Temasek Life Sciences Private Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":9,"first":"2009-04-30","last":"2019-10-18","span_basis":"filed_date"},"name_variants":[{"name":"Temasek Life Sciences Private Ltd","source":"filing","n_filings":3,"first_seen":"2016-05-13","last_seen":"2019-10-18"},{"name":"Temasek Life Sciences Private LTD","source":"filing","n_filings":6,"first_seen":"2009-04-30","last_seen":"2009-05-22"}],"transactions":[{"id":8091773,"accession":"0000899243-19-025766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-025766","line_url":"/filing/0000899243-19-025766#line-3","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"TLS Beta Pte. Ltd.; Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; Temasek Holdings (Private) Ltd; Temasek Life Sciences Private Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":5499999.0,"shares_owned_after_display":"5,499,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-16","filed_date":"2019-10-18","scope":"insider"},{"id":6435827,"accession":"0000899243-18-009413","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-18-009413","line_url":"/filing/0000899243-18-009413#line-3","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Homology Medicines, Inc.","issuer_ticker":"FIXX","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"Temasek Holdings (Private) Ltd; Fullerton Management Pte Ltd; TLS Beta Pte. Ltd.; Temasek Life Sciences Private Ltd; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":3220293.0,"shares_owned_after_display":"3,220,293","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":2495242,"accession":"0000899243-16-019823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-019823","line_url":"/filing/0000899243-16-019823#line-2","is_derivative":false,"issuer_cik":"0001021944","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001021944","owner_cik":null,"owner_name":"Temasek Life Sciences Private Ltd; Fullerton Management Pte Ltd; Temasek Holdings (Private) Ltd; TLS Beta Pte. Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5400000.0,"total_display":"5,400,000.00","shares_owned_after":790527.0,"shares_owned_after_display":"790,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-13","scope":"insider"},{"id":5626363,"accession":"0001209191-09-028454","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-21","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8520.0,"shares_display":"8,520","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":23430.0,"total_display":"23,430.00","shares_owned_after":4041424.0,"shares_owned_after_display":"4,041,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626362,"accession":"0001209191-09-028454","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-20","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":2.74,"price_display":"2.74","price_state":"stated","total_value":23016.0,"total_display":"23,016.00","shares_owned_after":4049944.0,"shares_owned_after_display":"4,049,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626361,"accession":"0001209191-09-028454","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-19","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8100.0,"shares_display":"8,100","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":21870.0,"total_display":"21,870.00","shares_owned_after":4070024.0,"shares_owned_after_display":"4,070,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626360,"accession":"0001209191-09-028454","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-18","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7520.0,"shares_display":"7,520","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":20379.2,"total_display":"20,379.20","shares_owned_after":4062504.0,"shares_owned_after_display":"4,062,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626359,"accession":"0001209191-09-028454","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-17","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":11298.0,"total_display":"11,298.00","shares_owned_after":4078124.0,"shares_owned_after_display":"4,078,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626358,"accession":"0001209191-09-028454","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-16","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":8556.0,"total_display":"8,556.00","shares_owned_after":4038324.0,"shares_owned_after_display":"4,038,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626357,"accession":"0001209191-09-028454","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-15","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":6968.0,"total_display":"6,968.00","shares_owned_after":4082324.0,"shares_owned_after_display":"4,082,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626356,"accession":"0001209191-09-028454","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-14","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":6371.0,"total_display":"6,371.00","shares_owned_after":4036024.0,"shares_owned_after_display":"4,036,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626355,"accession":"0001209191-09-028454","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-13","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2180.0,"shares_display":"2,180","price_per_share":2.73,"price_display":"2.73","price_state":"stated","total_value":5951.4,"total_display":"5,951.40","shares_owned_after":4058344.0,"shares_owned_after_display":"4,058,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626354,"accession":"0001209191-09-028454","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-12","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":5385.6,"total_display":"5,385.60","shares_owned_after":4060524.0,"shares_owned_after_display":"4,060,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626353,"accession":"0001209191-09-028454","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-11","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":2.78,"price_display":"2.78","price_state":"stated","total_value":1668.0,"total_display":"1,668.00","shares_owned_after":4035424.0,"shares_owned_after_display":"4,035,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-21","filed_date":"2009-05-22","scope":"insider"},{"id":5626352,"accession":"0001209191-09-028454","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-10","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":10575.0,"total_display":"10,575.00","shares_owned_after":4095972.0,"shares_owned_after_display":"4,095,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626351,"accession":"0001209191-09-028454","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-9","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2948.0,"shares_display":"2,948","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":7045.72,"total_display":"7,045.72","shares_owned_after":4084924.0,"shares_owned_after_display":"4,084,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626350,"accession":"0001209191-09-028454","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-8","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":6183.0,"total_display":"6,183.00","shares_owned_after":4091972.0,"shares_owned_after_display":"4,091,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626349,"accession":"0001209191-09-028454","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-7","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":4893.0,"total_display":"4,893.00","shares_owned_after":4087872.0,"shares_owned_after_display":"4,087,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626348,"accession":"0001209191-09-028454","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-6","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":2.32,"price_display":"2.32","price_state":"stated","total_value":2088.0,"total_display":"2,088.00","shares_owned_after":4089972.0,"shares_owned_after_display":"4,089,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626347,"accession":"0001209191-09-028454","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-5","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":1610.0,"total_display":"1,610.00","shares_owned_after":4091272.0,"shares_owned_after_display":"4,091,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626346,"accession":"0001209191-09-028454","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-4","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":2.2717,"price_display":"2.27","price_state":"stated","total_value":1363.02,"total_display":"1,363.02","shares_owned_after":4095072.0,"shares_owned_after_display":"4,095,072","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626345,"accession":"0001209191-09-028454","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.31,"price_display":"2.31","price_state":"stated","total_value":924.0,"total_display":"924.00","shares_owned_after":4090872.0,"shares_owned_after_display":"4,090,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626344,"accession":"0001209191-09-028454","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.2725,"price_display":"2.27","price_state":"stated","total_value":909.0,"total_display":"909.00","shares_owned_after":4094672.0,"shares_owned_after_display":"4,094,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5626343,"accession":"0001209191-09-028454","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-028454","line_url":"/filing/0001209191-09-028454#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; V-Sciences Investments Pte Ltd; TEMASEK HOLDINGS (PRIVATE) LTD; Temasek Life Sciences Private LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":678.0,"total_display":"678.00","shares_owned_after":4095672.0,"shares_owned_after_display":"4,095,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-20","filed_date":"2009-05-22","scope":"insider"},{"id":5985825,"accession":"0001209191-09-027843","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-7","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7698.0,"shares_display":"7,698","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":17320.5,"total_display":"17,320.50","shares_owned_after":4102672.0,"shares_owned_after_display":"4,102,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-19","filed_date":"2009-05-20","scope":"insider"},{"id":5985822,"accession":"0001209191-09-027843","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-6","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":3164.0,"total_display":"3,164.00","shares_owned_after":4101272.0,"shares_owned_after_display":"4,101,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-19","filed_date":"2009-05-20","scope":"insider"},{"id":5985819,"accession":"0001209191-09-027843","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-5","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":681.0,"total_display":"681.00","shares_owned_after":4100672.0,"shares_owned_after_display":"4,100,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-19","filed_date":"2009-05-20","scope":"insider"},{"id":5985816,"accession":"0001209191-09-027843","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-4","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.265,"price_display":"2.26","price_state":"stated","total_value":679.5,"total_display":"679.50","shares_owned_after":4100972.0,"shares_owned_after_display":"4,100,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-19","filed_date":"2009-05-20","scope":"insider"},{"id":5985814,"accession":"0001209191-09-027843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31164.0,"shares_display":"31,164","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":70119.0,"total_display":"70,119.00","shares_owned_after":4114288.0,"shares_owned_after_display":"4,114,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-18","filed_date":"2009-05-20","scope":"insider"},{"id":5985812,"accession":"0001209191-09-027843","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3550.0,"shares_display":"3,550","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":8058.5,"total_display":"8,058.50","shares_owned_after":4110370.0,"shares_owned_after_display":"4,110,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-18","filed_date":"2009-05-20","scope":"insider"},{"id":5985809,"accession":"0001209191-09-027843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-027843","line_url":"/filing/0001209191-09-027843#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":368.0,"shares_display":"368","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":831.68,"total_display":"831.68","shares_owned_after":4113920.0,"shares_owned_after_display":"4,113,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-18","filed_date":"2009-05-20","scope":"insider"},{"id":5589200,"accession":"0001209191-09-027174","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-10","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16239.0,"shares_display":"16,239","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":36537.75,"total_display":"36,537.75","shares_owned_after":4151317.0,"shares_owned_after_display":"4,151,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589199,"accession":"0001209191-09-027174","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-9","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2365.0,"shares_display":"2,365","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":5344.9,"total_display":"5,344.90","shares_owned_after":4148952.0,"shares_owned_after_display":"4,148,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589198,"accession":"0001209191-09-027174","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-8","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":2951.0,"total_display":"2,951.00","shares_owned_after":4147652.0,"shares_owned_after_display":"4,147,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589197,"accession":"0001209191-09-027174","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-7","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":2280.0,"total_display":"2,280.00","shares_owned_after":4146252.0,"shares_owned_after_display":"4,146,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589196,"accession":"0001209191-09-027174","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-6","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":1840.0,"total_display":"1,840.00","shares_owned_after":4145452.0,"shares_owned_after_display":"4,145,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589195,"accession":"0001209191-09-027174","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-5","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.275,"price_display":"2.28","price_state":"stated","total_value":910.0,"total_display":"910.00","shares_owned_after":4147252.0,"shares_owned_after_display":"4,147,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-15","filed_date":"2009-05-18","scope":"insider"},{"id":5589194,"accession":"0001209191-09-027174","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-4","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39800.0,"shares_display":"39,800","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":89550.0,"total_display":"89,550.00","shares_owned_after":4174256.0,"shares_owned_after_display":"4,174,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-14","filed_date":"2009-05-18","scope":"insider"},{"id":5589193,"accession":"0001209191-09-027174","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":13334.0,"total_display":"13,334.00","shares_owned_after":4168256.0,"shares_owned_after_display":"4,168,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-14","filed_date":"2009-05-18","scope":"insider"},{"id":5589192,"accession":"0001209191-09-027174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":1589.0,"total_display":"1,589.00","shares_owned_after":4167556.0,"shares_owned_after_display":"4,167,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-14","filed_date":"2009-05-18","scope":"insider"},{"id":5589191,"accession":"0001209191-09-027174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-027174","line_url":"/filing/0001209191-09-027174#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.2525,"price_display":"2.25","price_state":"stated","total_value":225.25,"total_display":"225.25","shares_owned_after":4174156.0,"shares_owned_after_display":"4,174,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-14","filed_date":"2009-05-18","scope":"insider"},{"id":5710265,"accession":"0001209191-09-026263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-026263","line_url":"/filing/0001209191-09-026263#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39453.0,"shares_display":"39,453","price_per_share":2.2803,"price_display":"2.28","price_state":"stated","total_value":89964.6759,"total_display":"89,964.68","shares_owned_after":4214056.0,"shares_owned_after_display":"4,214,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-12","filed_date":"2009-05-13","scope":"insider"},{"id":5710264,"accession":"0001209191-09-026263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-026263","line_url":"/filing/0001209191-09-026263#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69300.0,"shares_display":"69,300","price_per_share":2.2941,"price_display":"2.29","price_state":"stated","total_value":158981.13,"total_display":"158,981.13","shares_owned_after":4253509.0,"shares_owned_after_display":"4,253,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-11","filed_date":"2009-05-13","scope":"insider"},{"id":5681853,"accession":"0001209191-09-025706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-025706","line_url":"/filing/0001209191-09-025706#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129600.0,"shares_display":"129,600","price_per_share":2.3842,"price_display":"2.38","price_state":"stated","total_value":308992.32,"total_display":"308,992.32","shares_owned_after":4322809.0,"shares_owned_after_display":"4,322,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-08","filed_date":"2009-05-11","scope":"insider"},{"id":5681852,"accession":"0001209191-09-025706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-025706","line_url":"/filing/0001209191-09-025706#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"V-Sciences Investments Pte Ltd; Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":205260.0,"shares_display":"205,260","price_per_share":2.3626,"price_display":"2.36","price_state":"stated","total_value":484947.276,"total_display":"484,947.28","shares_owned_after":4452409.0,"shares_owned_after_display":"4,452,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-07","filed_date":"2009-05-11","scope":"insider"},{"id":5784434,"accession":"0001209191-09-023497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-023497","line_url":"/filing/0001209191-09-023497#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122410.0,"shares_display":"122,410","price_per_share":2.2794,"price_display":"2.28","price_state":"stated","total_value":279021.354,"total_display":"279,021.35","shares_owned_after":4657669.0,"shares_owned_after_display":"4,657,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-29","filed_date":"2009-04-30","scope":"insider"},{"id":5784431,"accession":"0001209191-09-023497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-023497","line_url":"/filing/0001209191-09-023497#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"VICAL INC","issuer_ticker":"VICL","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Fullerton Management Pte Ltd; Temasek Life Sciences Private LTD; TEMASEK HOLDINGS (PRIVATE) LTD; V-Sciences Investments Pte Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":2.5287,"price_display":"2.53","price_state":"stated","total_value":505740.0,"total_display":"505,740.00","shares_owned_after":4780079.0,"shares_owned_after_display":"4,780,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-28","filed_date":"2009-04-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Ten percent owner","n_filings":1,"first_seen":"2019-10-18","last_seen":"2019-10-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Homology Medicines, Inc.","url":"/issuer/0001661998","role":"Ten percent owner","n_filings":1,"first_seen":"2018-04-04","last_seen":"2018-04-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-13","last_seen":"2016-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0000819050","name":"VICAL INC","url":"/issuer/0000819050","role":"Ten percent owner","n_filings":6,"first_seen":"2009-04-30","last_seen":"2009-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379349","retrieved_at":"2026-08-21T02:51:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}